Codon Optimization and Expression of Norovirus apsid Proteins in Insect Cells

GUO Li; ZHOU Hong-li; QU Jian-guo; WANG Jian-wei; XU Xi-wei; HUNG Tao

PDF
Cite
Share

facebook

twitter

google

linkedin

April 2006

GUO Li, ZHOU Hong-li, QU Jian-guo, WANG Jian-wei, XU Xi-wei and HUNG Tao. Codon Optimization and Expression of Norovirus apsid Proteins in Insect Cells[J]. Virologica Sinica, 2006, 21(2): 121-125.

Citation: GUO Li, ZHOU Hong-li, QU Jian-guo, WANG Jian-wei, XU Xi-wei, HUNG Tao. Codon Optimization and Expression of Norovirus apsid Proteins in Insect Cells .VIROLOGICA SINICA, 2006, 21(2) : 121-125.

人诺如病毒衣壳蛋白的密码子优化及在昆虫细胞中的表达

郭丽 ¹ ,
周红莉 ¹ ,
屈建国 ¹ ,
王健伟 ^1*,, ,
徐樨巍 ² ,
洪涛 ¹

1.
1.中国疾病预防控制中心病毒病预防控制研究所，北京 100052
2.
北京儿童医院，北京 100045

通讯作者： 王健伟, ;

摘要

诺如病毒是当前在中国引起腹泻的主要人类杯状病毒，其中GGII4、GGII1和GGII3等为主要的流行遗传型。为了提高诺如病毒衣壳蛋白的表达量，我们将其编码基因按杆状病毒喜用密码子进行了优化设计和人工合成。以杆状病毒为载体，在昆虫细胞Sf9中对密码子优化后的诺如病毒GGII1、GGII3、GGII4和GGII7型衣壳蛋白基因进行了表达。结果显示，与野生型基因相比，经过密码子优化的基因在昆虫细胞中的表达水平得到明显提高，并可装配成病毒样颗粒。重组杆状病毒感染Sf9细胞72h表达量达到高峰。这些结果的取得，为我国人杯状病毒免疫学检测试剂和疫苗的开发打下了基础。
- 诺如病毒
- , 衣壳蛋白
- , 杆状病毒载体
- , 表达
- , 病毒样颗粒

Codon Optimization and Expression of Norovirus apsid Proteins in Insect Cells

GUO Li ¹ ,
ZHOU Hong-li ¹ ,
QU Jian-guo ¹ ,
WANG Jian-wei ^1*,, ,
XU Xi-wei ² ,
HUNG Tao ¹

1.
1.National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China
2.
BeiJing Children’s Hospital, Beijing 100045, China

Corresponding author: WANG Jian-wei,

Abstract

Norovirus is currently the predominant human calicivirus that causes diarrhea in China. Among the documented noroviruses, types 4, 1 and 3 are the leading genetics groups. In order to improve the expression of the norovirus capsid, we re-designed and artificially synthesized the full-length norovirus capsid genes by adopting the codons preferentially used in insect cells without any changing of the amino acid sequences. The codon optimized capsid genes of Norovirus GGII1, GGII3, GGII4 and GGII7 were respectively expressed in insect cell Sf9 using baculovirus vector. The results showed that, compared to the wild type, the expression levels of the optimized genes were remarkably increased. The assembly of norovirus-like particles was observed in the Sf9 cells infected with the recombinant baculovirus expressing the capsid protein. The recombinant capsid expression peaked at 72h post infection of the recombinant baculoviruses. The results obtained in the present work will lay a foundation for the development of the immunological diagnostic reagents as well as vaccines for human caliciviruses.
- Norovirus
- , Capsid
- , Virus-like particle
- , Expression
- , Codon optimization

References
Proportional views

PDF

Article Metrics

Article views(4687) PDF downloads(1242) Cited by(0)

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Codon Optimization and Expression of Norovirus apsid Proteins in Insect Cells

Corresponding author: WANG Jian-wei,

1. 1.National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China
2. BeiJing Children’s Hospital, Beijing 100045, China

Abstract: Norovirus is currently the predominant human calicivirus that causes diarrhea in China. Among the documented noroviruses, types 4, 1 and 3 are the leading genetics groups. In order to improve the expression of the norovirus capsid, we re-designed and artificially synthesized the full-length norovirus capsid genes by adopting the codons preferentially used in insect cells without any changing of the amino acid sequences. The codon optimized capsid genes of Norovirus GGII1, GGII3, GGII4 and GGII7 were respectively expressed in insect cell Sf9 using baculovirus vector. The results showed that, compared to the wild type, the expression levels of the optimized genes were remarkably increased. The assembly of norovirus-like particles was observed in the Sf9 cells infected with the recombinant baculovirus expressing the capsid protein. The recombinant capsid expression peaked at 72h post infection of the recombinant baculoviruses. The results obtained in the present work will lay a foundation for the development of the immunological diagnostic reagents as well as vaccines for human caliciviruses.